How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

As Oracle slashes jobs, some workers say they were helping develop the AI that displaced them.

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Tech giant Oracle on May 13 released new renderings and details about a forthcoming Nashville pedestrian bridge planned to ...

Oracle continues to build a durable position for the next phase of the AI cycle, where infrastructure, performance, and data ...

Some found out they didn't qualify for WARN Act protections like two-months notice because the company had classified them as remote workers.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min More renderings were unveiled of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.